This market asks whether any actual fission or fusion nuclear explosion occurs anywhere during calendar 2026; missile launches, nuclear exercises, conventional attacks, and chemical-explosive experiments do not qualify. As of October 24, research found no confirmed or officially declared detonation this year, and CTBTO reports no detected or declared test explosion since 2017, while noting that very low-yield events can be harder to characterize. The remaining weeks carry a nonzero risk: renewed U.S. testing rhetoric and broader geopolitical tensions are concerning, but experts describe practical and political constraints on restarting tests, and there is no evidence of an imminent detonation. External market search returned no relevant market for this exact outcome, so the quote reflects the low base rate and limited time remaining, tempered by those risks.
At an October CTBT anniversary briefing, experts said unconfirmed low-yield test allegations and U.S. rhetoric could weaken restraint; they reported no state openly violating the treaty.
U.S. demands for a reduction in Iran’s enrichment capacity and Tehran’s rejection of the terms left nuclear diplomacy unresolved; this does not itself establish any nuclear detonation.
The agency said the September experiment used chemical high explosives and radiotracers to improve detection of low-yield nuclear explosions; it was not a nuclear detonation.
Pyongyang rejected the appeal and reiterated its nuclear-weapons status, keeping testing concerns in view but not announcing a detonation.
A study published in Science reported that seismic activity around Mt. Mantap intensified for years after the 2017 nuclear test. The reported events are small earthquakes through 2025, not evidence of a 2026 nuclear detonation.
